Importantly, the translocation of the ABCG2 drug transporter away from the plasma membrane resulted in a concomitant decrease in doxorubicin extrusion in thyroid cancer cell lines (Lopez et al. 2007). This evidence concerns the gene ABCG2 and thyroid cancer.